Skip to main content
    S

    Silexion Therapeutics Corp (SLXN)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $1.76
    -0.22 (-11.11%)

    Market Cap: $1.29M

    Last updated: Nov 17, 2026 at 11:02 AM ET

    Earnings

    Performance (10Y)

    Beat Rate
    50%(2/4)
    Avg Surprise
    -30.11%

    Upcoming Estimates

    Report date not yet scheduledPeriod ending Dec 31, 2026
    EPS Consensus-$0.72
    RangeN/A
    3 analysts
    Revenue Consensus
    N/A
    RangeN/A
    Last 12 of 23 reported quarters and 1 upcoming estimate
    PeriodReportedEst.RangeSurpriseB/MAnalystsRevisionsYoY
    Dec 26EST
    Date TBD
    --$0.72N/A--3--
    Sep 26
    Reported Nov 12
    -$13.70-$0.91-$0.91 - -$0.91--1
    1
    0
    30d
    +52.4%
    Jun 26
    Reported Aug 14
    -$5.17-$2.12-$2.12 - -$2.12-143.87%Miss1
    0
    1
    30d
    -19.7%
    Mar 26
    Reported May 15
    -$8.50-$12.90-$12.90 - -$12.90+34.11%Beat1
    No revisions (30d)
    -3221.6%
    Dec 25
    Reported Mar 17
    -$14.11-$11.20-$11.70 - -$10.70-25.99%Miss2
    1
    0
    30d
    +99.5%
    Sep 25
    Reported Nov 12
    -$28.80-$34.00N/A+15.29%Beat--+98.9%
    Jun 25
    Reported Aug 12
    -$4.32-$0.21N/A--0
    No revisions (30d)
    -15001.7%
    Mar 25
    Reported May 13
    -$0.26N/AN/A--0
    No revisions (30d)
    -395.0%
    Dec 24
    Reported Mar 18
    -$3,114.00-$147.00N/A-----3008.1%
    Sep 24
    Reported Nov 14
    -$2,740.50-$148.50N/A-----13722.1%
    Jun 24
    Reported Aug 13
    -$0.03N/AN/A-----100.1%
    Mar 24
    Reported May 15
    -$0.05N/AN/A-----100.1%
    Dec 23
    Reported Dec 31
    -$100.19N/AN/A-----334061.0%

    Key Metrics

    Valuation
    P/E RatioN/AEV/EBITDAN/A
    Price/FCFN/AFCF YieldN/A
    Profitability
    Profit Margin0.00%Operating Margin0.00%
    ROE-897.00%ROICN/A
    Financial Health
    Debt/Equity0.00xInterest CoverageN/A
    Current Ratio1.66xQuick Ratio1.66x
    Trading Statistics
    Beta-0.29Avg Volume913.05K
    52-Week High$777.1252-Week Low$1.82

    Technical Indicators Dashboard

    As of Nov 16, 2026, the price is 68.4% below its 50-day moving average, and the 50-day average is below the 200-day average. The 14-day RSI is 27.6, below 30, the oversold line.

    Moving Averages

    SMA 10$2.95
    SMA 20$3.40
    SMA 50$5.56
    SMA 200$132.75
    EMA 10$2.78
    EMA 20$3.45
    EMA 50$9.45
    EMA 200$260.28

    MACD

    Line: -1.10Signal: -1.17Hist: 0.07

    ADX

    ADX: 32.0+DI: 5.9-DI: 1.9

    Aroon & PSAR

    Aroon Up88.0
    Aroon Down84.0
    PSAR$0.33

    Bollinger Bands

    Upper Band$4.80
    Lower Band$2.00
    %B Position8243%(Upper)
    Band Width-0.08

    RSI (14-Day)

    Oversold
    27.6

    Momentum Oscillators

    Stoch %K53.6
    Stoch %D373.2
    Williams %R-56.3
    ROC (10d)-50.6%
    Momentum-1.80
    CCI (20d)45.4
    MFI (14d)44.9

    Volatility Measures

    ATR (14d)$3.68(209.4%)
    StdDev (20d)0.70
    Hist Vol176.0%(High)

    Volume Flow

    VWAP$1.83
    OBV584.4M
    AD Line2956.6B
    CMF (20d)382.753

    Volume Metrics

    Avg Vol (20d)702.6K
    Vol Ratio0.0x(Low)
    VWMA (20d)$3.86

    Pivot Points

    R3$3.26
    R2$2.94
    R1$2.46
    Pivot Point$2.14
    S1$1.66
    S2$1.34
    S3$0.86

    Advanced Oscillators

    TSI-37.09
    Ultimate Osc82.9
    KST-425.02

    Financial Performance

    Related GNG Research

    No research available

    Be the first to write about SLXN

    News

    SLXN Valuation

    SLXN Profitability: Margins, ROIC and FCF

    Silexion Therapeutics (SLXN) has an operating margin of 0.0% and a net margin of 0.0%. It posts a -21349.1% FCF margin.

    Operating margin
    0.0%
    Net margin
    0.0%
    ROE
    -897.0%
    FCF margin
    -21349.1%
    SLXN financial statements

    Silexion Therapeutics Competitors

    The companies most similar to Silexion Therapeutics (SLXN) include Bone Biologics, Scinai Immunotherapeutics and BioRestorative Therapies.

    Sector: Healthcare

    Companies most similar to Silexion Therapeutics

    SLXN Earnings: Beat Rate and Next Report

    Silexion Therapeutics (SLXN) beat the EPS estimate in 2 of the 4 most recent quarters that had an estimate (50.0%).

    Beat rate
    2 of 4 quarters (50.0%)
    Average surprise
    -30.1%
    EPS estimate (fiscal period ending Dec 31, 2026)
    -$0.72

    Updated Nov 12, 2026. Built from end-of-day prices, company filings and consensus analyst estimates. Methodology

    Frequently Asked Questions About SLXN

    Does SLXN pay dividends?

    Silexion Therapeutics Corp (SLXN) does not currently pay a regular dividend.

    What is SLXN's market cap?

    Silexion Therapeutics Corp (SLXN) has a market capitalization of $1.29M with a current stock price of $1.76.

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.